Target intelligence / Profile preview

Myocardial cell apoptosis pathway

Molecular classification
Other (Signaling pathway), Apoptosis pathway, Mitochondrial pathway, Death receptor pathway
01

Overview

The myocardial cell apoptosis pathway refers to a network of signaling cascades that mediate programmed cell death in cardiomyocytes. This process involves both intrinsic (mitochondrial-mediated) and extrinsic (death receptor-mediated) pathways, with critical roles for Bcl-2 family proteins, caspases, and cellular organelles such as mitochondria. Dysregulation of apoptosis in myocardial tissue is implicated in the pathogenesis of heart failure, myocardial infarction, and cardiotoxicity associated with chemotherapeutic agents. Various molecules within these pathways, such as caspases, Bcl-2 family members, and death receptors, have been investigated as potential therapeutic targets, but the pathway itself is not a single pharmacological target.

Other names
Cardiomyocyte apoptosis pathwaycardiac muscle apoptosis pathwayapoptotic signaling in cardiomyocytes
02

Mechanism of action

Inhibition or activation of caspases (caspase-3, caspase-8, caspase-9) Modulation of Bcl-2 family proteins (pro- and anti-apoptotic) Inhibition of mitochondrial permeability transition and cytochrome c release Regulation of MAPK signaling pathways (ERK, JNK, p38) Blocking death receptor (e.g., Fas/TNF receptors) pathways Inhibition of NLRP3 inflammasome/pyroptosis (for agents like MCC950)

03

Biological functions

ApoptosisCell deathRegulation of cell survivalResponse to cardiac injury/stress
04

Disease associations

Cardiovascular disease (especially heart failure, myocardial infarction, drug-induced cardiomyopathy)
05

Safety considerations

Inhibition of apoptosis may promote cancer or interfere with tissue homeostasisSystemic effects if inhibitors are not cardiomyocyte-selectiveSome drugs (e.g., doxorubicin) cause off-target apoptosis leading to cardiotoxicity
06

Interacting drugs

Doxorubicin

2 more in the full profile.

07

Biomarkers

Activated caspase-3, -8, -9Cleaved PARPCytochrome c releaseBax/Bcl-2 ratioTUNEL staining (for apoptosis detection)N-terminal proBNP (indirect in context of heart failure)Troponin (indirect, for cell death)

Beyond the preview

Go deeper on Myocardial cell apoptosis pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myocardial cell apoptosis pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call